Anika Therapeutics | ANIK - Stock


Anika Therapeutics reported $18.79M in Stock for its fiscal quarter ending in December of 2025.





Stock Change Date
Abbott USD 6.49B 220M Dec/2025
Agios Pharmaceuticals USD 32.92M 886K Dec/2025
Anika Therapeutics USD 18.79M 2.5M Dec/2025
Arrowhead Research USD -173.08M 173.08M Dec/2024
Halozyme Therapeutics USD 176.48M 9.32M Dec/2025
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Insmed USD 132.07M 11.1M Dec/2025
Integra LifeSciences USD 492.73M 3.63M Dec/2025
Intrexon USD 287K 68K Dec/2022
J&J USD 14.19B 45M Dec/2025
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
Ligand Pharmaceuticals USD 9.13M 2.77M Dec/2025
MacroGenics USD 7.91M 840K Dec/2025
Merit Medical Systems USD 333.7M 7.15M Dec/2025
Rigel Pharmaceuticals USD 13.3M 2.88M Sep/2025
Sanofi EUR 22.69B 1.81B Dec/2025
Stryker USD 5.31B 60M Dec/2025
Surmodics USD 15.17M 230K Sep/2024
Veracyte USD 20.55M 219K Dec/2025
Zimmer Biomet Holdings USD 2.29B 197.3M Dec/2025